Simcere gets NMPA approval to market Yingmule in China
Simcere Pharmaceutical Group Ltd says China’s NMPA has approved marketing of Yingmule in China.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.